Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT01898715 |
| Title | Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Millendo Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
| National Institutes of Health/National Cancer Institute | Bethesda | Maryland | 20892 | United States | Details | |
| University of Michigan Cancer Center | Ann Arbor | Michigan | 48103 | United States | Details | |
| MDAnderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg | Würzburg | Germany | Details |